Prophylaxis Versus Preemptive Therapy for Prevention of Human Cytomegalovirus Disease in Pediatric Liver Transplant Recipients

被引：0
|
作者：
Gerna, Giuseppe [1 ]
Lilleri, Daniele [1 ]
Torre, Giuliano [2 ]
机构：
[1] Policlin San Matteo, Fdn IRCSS, Serv Virol, I-27100 Pavia, Italy
[2] Osped Riuniti Bergamo, Div Pediat, I-24100 Bergamo, Italy
来源：
TRANSPLANTATION | 2009年 / 87卷 / 02期
关键词：
D O I：
10.1097/TP.0b013e3181938beb
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [41] A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients
    Reischig, Tomas
    Vlas, Tomas
    Kacer, Martin
    Pivovarcikova, Kristyna
    Lysak, Daniel
    Nemcova, Jana
    Drenko, Petr
    Machova, Jana
    Bouda, Mirko
    Sedivcova, Monika
    Kormunda, Stanislav
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 34 (05): : 920 - 934
  • [42] Comparison of CMV prophylaxis and preemptive therapy in liver and kidney transplant recipients.
    Taber, DJ
    Dupuis, RE
    Hollar, KD
    Meehan, A
    Rodegast, B
    Salm, J
    Zacks, S
    Shrestha, R
    Gerber, D
    Johnson, MW
    TRANSPLANTATION, 2000, 69 (08) : S181 - S181
  • [43] Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients
    Park, Jeong M.
    Lake, Kathleen D.
    Fontana, Robert J.
    LIVER TRANSPLANTATION, 2006, 12 (06) : 1022 - 1023
  • [44] Effectiveness of Preemptive Therapy in the Prevention of Cytomegalovirus (CMV) Disease in High-Risk (Donor Seropositive/Recipient Seronegative) Liver Transplant Recipients
    Morillas, J. A.
    Brizendine, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 785 - 786
  • [45] Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients
    Onor, IfeanyiChukwu O.
    Todd, Sarah B.
    Meredith, Erika
    Perez, Sebastian D.
    Mehta, Aneesh K.
    Lyon, G. Marshall
    Knechtle, Stuart J.
    Hanish, Steven I.
    TRANSPLANT INTERNATIONAL, 2013, 26 (06) : 592 - 600
  • [46] Evaluation of a Surveillance after Prophylaxis Strategy for Cytomegalovirus Prevention in Liver Transplant Recipients
    Parrish, N.
    Webb, A.
    Kaiser, T.
    Shah, S.
    Anwar, N.
    Luckett, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 778 - 779
  • [47] Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients
    Gerna, G.
    Lilleri, D.
    Rognoni, V.
    Agozzino, M.
    Meloni, F.
    Oggionni, T.
    Pellegrini, C.
    Arbustini, E.
    D'Armini, A. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1142 - 1150
  • [48] CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS - IMPACT OF ACYCLOVIR PROPHYLAXIS
    KIZILISIK, TA
    PREIKSAITIS, JK
    KNETEMAN, NM
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (03) : 2282 - 2283
  • [49] Cytomegalovirus Treatment Strategy After a Liver Transplant: Preemptive Therapy or Prophylaxis for Cytomegalovirus Seropositive Donor and Recipient
    Lindner, Kirsten
    Anthoni, Christoph
    Beckebaum, Susanne
    Senninger, Norbert
    Hoelzen, Jens Peter
    Wolters, Heiner
    Experimental and Clinical Transplantation, 2016, 14 (04) : 419 - 423
  • [50] Comparison of valganciclovir vs. intravenous ganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients
    Clark, BS
    Chang, IF
    Karpen, SJ
    Herrera, L
    Goss, JA
    Scott, JD
    Bristow, LJ
    Quiros-Tejeira, RE
    LIVER TRANSPLANTATION, 2003, 9 (06) : C30 - C30
12345